Neonate pertacuneous jaundice tester and client

Abstract

The invention provides a neonate pertacuneous jaundice tester comprising the following elements: a lighting module used for alternatively emitting a first light ray and a second light ray to a neonate according to a preset frequency under the control of a control module, wherein the first and second light rays contain the lights different from a preset wavelength and used for measuring the neonate bilirubin real concentration; a light acquisition module controlled by the control module so as to regularly collect first and second light rays emitted into and reflected from the neonate skin, and the collected light rays are converted to obtain corresponding a first signal and a second signal; a communication module used for outputting the first and second electric signals so as to allow the terminal, having the bilirubin concentration information, to real time monitor the neonate bilirubin concentration, thus making fast diagnosis reaction when the neonate bilirubin concentration is abnormal, reducing neonate sickening risks in the maximum level, and ensuring neonate health.

Description

technical field [0001] The invention belongs to the technical field of measuring instruments, and in particular relates to a neonatal transcutaneous jaundice instrument and a client. Background technique [0002] Medically, the jaundice of newborns under the full moon (within 28 days of birth) is called neonatal jaundice. Neonatal jaundice refers to the abnormal bilirubin metabolism in the neonatal period, which causes the bilirubin concentration in the blood to increase, and appears in the skin, mucous membrane and sclera yellow staining. The disease can be divided into physiological and pathological. Physiological jaundice appears 2 to 3 days after birth, peaks at 4 to 6 days, subsides at 7 to 10 days, and lasts longer in premature infants. Except for a slight loss of appetite, there are no other clinical symptoms. If jaundice occurs 24 hours after birth, the daily serum bilirubin rises more than 5 mg / dl or >0.5 mg / dl per hour; the duration is long, full-term infants &...

AI Technical Summary

Problems solved by technology

[0004] However, the existing handheld transcutaneous jaundice instrument has the following problems: the existing handheld transcutaneous jaundice instrument is a single reading measurement, which cannot realize 24-hour real-time monitoring. , it is difficult to determine the abnormal bilirubin concentration at the first time, and it is impossible to make a rapid diagnostic response

In addition, the dual-wavelength method adopted by the existing transdermal jaundice instrument only considers the influence of hemoglobin on the measurement, but there is also a certain share of melanin’s light absorption at the wavelength of 460nm, which means that the existing dual-wavelength method cannot remove the baby’s skin color. interference with the measurement

Moreover, the existing hand-held transcutaneous jaundice instrument is large in size and poor in portability. Manual participation is required for each measurement, which is inconvenient for multiple measurements

At the same time, the function is relatively single, and it is impossible to check other physiological indicators of other babies while checking the baby's bilirubin

Images